B-ENT
Case Report

Rhino-Sinusal Mucormycosis: About the Management of 2 Clinical Cases

1.

Department of ENT, University of Liege and University Hospital of Liège, Sart-Tilman, Belgium

2.

Department of Pathology, University of Liege, University Hospital of Liège, Sart-Tilman, Belgium

3.

Department of Nephrology, University of Liege, University Hospital of Liège, Sart-Tilman, Belgium

4.

Department of ENT, Centre Hospitalier Régional de la Citadelle, Liège, Belgium

5.

Department of Medical Imaging, University of Liege, University Hospital of Liège, Sart-Tilman, Belgium

6.

Department of Neurosurgery, University of Liege, University Hospital of Liege, Sart-Tilman, Belgium

B-ENT 2023; 19: 180-183
DOI: 10.5152/B-ENT.2023.22942
Read: 267 Downloads: 128 Published: 04 October 2023

Mucormycosis is a fungal infection with a high mortality rate due to a fungus of the mucorales order, ubiquitous in our environment. It is an uncommon disease that occurs in severely immunocompromised patients, poorly controlled diabetics, or those on chronic immunosuppression or corticoid therapy. It can also develop in immunocompetent patients with cutaneous lesions, facilitating their installation. Symptomatology varies depending on its location (rhino-orbito-cerebral, cutaneous, pulmonary, disseminated, etc.). The cases reported describe the management of 2 patients who presented with rhino-sinusal mucormycosis infection 3 months apart in the same geographic area. The risk factors and the evolution of the pathology were different in these 2 patients. This text also includes an explanation of the pathophysiology, a summary of the different diagnostic techniques, and management recommendations.

Cite this article as: Ancion A, Mai-Liên Poirrier A, Dessard L, et al. Rhino-sinusal mucormycosis: About the management of 2 clinical cases. B-ENT. 2023;19(3):180-183.

Files
EISSN 2684-4907